Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Nutrition
Published in: European Journal of Nutrition 3/2018

01-04-2018 | Letter to the Editor

Research interactions between academia and food companies: how to improve transparency and credibility of an inevitable liaison

Authors: Andrea Poli, Franca Marangoni, Carlo V. Agostoni, Francesco Brancati, Lucio Capurso, Maria Laura Colombo, Andrea Ghiselli, Carlo La Vecchia, Enrico Molinari, Lorenzo Morelli, Marisa Porrini, Francesco Visioli, Gabriele Riccardi

Published in: European Journal of Nutrition | Issue 3/2018

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Mozaffarian D (2017) Conflict of interest and the role of the food industry in nutrition research. JAMA 317(17):1755–1756CrossRef
2.
Packer M (2017) Absence of an ideal observer II: the agonizing search for experts without a conflict of interest. Circulation 136(25):2400–2402
3.
Ioannidis JP (2016) We need more randomized trials in nutrition—preferably large, long-term, and with negative results. Am J Clin Nutr 103(6):1385–1386CrossRef
4.
Strom BL, Buyse M, Hughes J, Knoppers BM (2014) Data sharing, year 1—access to data from industry-sponsored clinical trials. N Engl J Med 371(22):2052–2054CrossRef
5.
Akl EA, El-Hachem P, Abou-Haidar H, Neumann I, Schünemann HJ, Guyatt GH (2014) Considering intellectual, in addition to financial, conflicts of interest proved important in a clinical practice guideline: a descriptive study. J Clin Epidemiol 67(11):1222–1228CrossRef
6.
Koletzko B, Demmelmair H, Grote V, Prell C, Weber M (2016) High protein intake in young children and increased weight gain and obesity risk. Am J Clin Nutr 103(2):303–304CrossRef
7.
Lüscher TF (2016) Conflicts of interest and the truth of scientific discovery: an editor’s perspective. Eur Heart J 37(9):738–740CrossRef
8.
Chartres N, Fabbri A, Bero LA (2016) Association of industry sponsorship with outcomes of nutrition studies: a systematic review and meta-analysis. JAMA Intern Med 176(12):1769–1777CrossRef
9.
10.
Ross JS, Gross CP, Krumholz HM (2012) Promoting transparency in pharmaceutical industry-sponsored research. Am J Public Health 102(1):72–80CrossRef
Metadata
Title
Research interactions between academia and food companies: how to improve transparency and credibility of an inevitable liaison
Authors
Andrea Poli
Franca Marangoni
Carlo V. Agostoni
Francesco Brancati
Lucio Capurso
Maria Laura Colombo
Andrea Ghiselli
Carlo La Vecchia
Enrico Molinari
Lorenzo Morelli
Marisa Porrini
Francesco Visioli
Gabriele Riccardi
Publication date
01-04-2018
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 3/2018
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-018-1633-1

Other articles of this Issue 3/2018

European Journal of Nutrition 3/2018 Go to the issue

Original Contribution

Effect of dietary alpha-linolenic acid on blood inflammatory markers: a systematic review and meta-analysis of randomized controlled trials

Review

Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis

Original Contribution

Comparable effects of breakfast meals varying in protein source on appetite and subsequent energy intake in healthy males

Original Contribution

Effects of tryptophan-containing peptides on angiotensin-converting enzyme activity and vessel tone ex vivo and in vivo

Original Contribution

Dietary blueberry improves cognition among older adults in a randomized, double-blind, placebo-controlled trial

Original Contribution

A low-dose, 6-week bovine colostrum supplementation maintains performance and attenuates inflammatory indices following a Loughborough Intermittent Shuttle Test in soccer players
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits